Alejandro CarpyGroup Leader at Roche
Dr. Alejandro Carpy is a Senior Scientist and Group Leader at Large Molecule Research in pharma Research and Early Development (pRED) at the Roche Innovation Center Munich. Among his responsibilities are the molecular assessment, analytical method development and method handover to the technical development function and the in-depth biophysical characterization of therapeutic antibodies and next generation biologics. He is involved in defining the analytical characterization strategy for several next generation biologics projects. He holds a PhD in Biochemistry from the University of Tübingen (Germany). Before joining Roche, he started his career at Novartis and worked at diverse sites gaining cross-functional experience in Quality, Production and Development.